
Race has historically been included in reference equations based on flawed assumptions about biological differences. In April 2023, the American Thoracic Society issued an official statement for clinicians that explains why race and ethnicity should no longer be considered factors in interpreting the results of spirometry, the most commonly used type of pulmonary function test (PFT). The statement was endorsed by the European Respiratory Society. The full statement is available in the American Journal of Respiratory and Critical Care Medicine.
To increase awareness of the ATS’s recommendations to use GLI Global rather than race/ethnicity-specific equations in PFT labs and clinical practice, the Society created this video as part of an Encoding Equity grant from The Counsel for Medical Specialty Societies (CMSS).
For more information on how institutional decision-makers, including hospital and health system leaders, can transition to GL1 Global, read the full statement here.
Hear directly from project leads Lauren Kearney, MD, and Sean Levy, MD, about adopting GL1 Global and why race is not an appropriate proxy for genetics or lung function differences.